Engineering GPCR signaling pathways with RASSLs

Nature Methods

Volumn 5, Issue 8, 2008, Pages 673-678

  Conklin, Bruce R ^a,b   Hsiao, Edward C ^a,b,c   Claeysen, Sylvie ^d,e   Dumuis, Aline ^d,e   Srinivasan, Supriya ^c   Forsayeth, John R ^c   Guettier, Jean Marc ^f   Chang, W C ^a,c   Pei, Ying ^g   McCarthy, Ken D ^g   Nissenson, Robert A ^a,c   Wess, Jürgen ^f   Bockaert, Joël ^d,e   Roth, Bryan L ^g  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^e UNIV MONTPELLIER   (France)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; 1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; 6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPINE; ASPARTIC ACID; ATIPAMEZOLE; ATROPINE; BENZAMIDE DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR; BIOGENIC AMINE; BRIMONIDINE; CISAPRIDE; CLONIDINE; CLOZAPINE N OXIDE; G 113808; G PROTEIN COUPLED RECEPTOR; HORMONE; NORBINALTORPHIMINE; RECEPTORS ACTIVATED SOLELY BY SYNTHETIC LIGANDS; SALVINORIN A; SEROTONIN 4 RECEPTOR; SPIRADOLINE; TETRAHYDROISOQUINOLINE;

ARTICLE; BONE GROWTH; DRUG SYNTHESIS; HUMAN; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; TISSUE ENGINEERING; WILD TYPE;

EID: 48449105746     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.1232     Document Type: Article

References (37)

1. Armbruster, B.N. & Roth, B.L. Mining the receptorome. J. Biol. Chem. 280, 5129-5132 (2005).
2. Wettschureck, N. & Offermanns, S. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85, 1159-1204 (2005).
3. Spiegel, A.M. & Weinstein, L.S. Inherited diseases involving G proteins and G protein-coupled receptors. Annu. Rev. Med. 55, 27-39 (2004).
4. Hopkins, A.L. & Groom, C.R. The druggable genome. Nat. Rev. Drug Discov. 1, 727-730 (2002).
5. Coward, P. et al. Controlling signaling with a specifically designed Gi-coupled receptor. Proc. Natl. Acad. Sci. USA 95, 352-357 (1998).
6. Small, K.M., Brown, K.M., Forbes, S.L. & Liggett, S.B. Modification of the beta 2-adrenergic receptor to engineer a receptor-effector complex for gene therapy. J. Biol. Chem. 276, 31596-31601 (2001).
7. Jacobson, K.A., Gao, Z.G. & Liang, B.T. Neoceptors: Reengineering GPCRs to recognize tailored ligands. Trends Pharmacol. Sci. 28, 111-116 (2007).
8. Armbruster, B.N., Li, X., Pausch, M.H., Herlitze, S. & Roth, B.L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl. Acad. Sci. USA 104, 5163-5168 (2007).
9. Strader, C.D. et al. Allele-specific activation of genetically engineered receptors. J. Biol. Chem. 266, 5-8 (1991).
10. Ballesteros, J.A. & Weinstein, H. Integrated methods for modeling G-protein coupled receptors. Meth. Neurosci. 25, 366-428 (1995).
11. Redfern, C.H. et al. Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat. Biotechnol. 17, 165-169 (1999).
12. Mueller, K.L. et al. The receptors and coding logic for bitter taste. Nature 434, 225-229 (2005).
13. Zhao, G.Q. et al. The receptors for mammalian sweet and umami taste. Cell 115, 255-266 (2003).
14. Redfern, C.H. et al. Conditional expression of a Gi-coupled receptor causes ventricular conduction delay and a lethal cardiomyopathy. Proc. Natl. Acad. Sci. USA 97, 4826-4831 (2000).
15. Sweger, E.J., Casper, K.B., Scearce-Levie, K., Conklin, B.R. & McCarthy, K.D. Development of hydrocephalus in mice expressing the G(i -coupted GPCR Ro1 RASSL receptor in astrocytes. J. Neurosci. 27, 2309-2317 (2007).
16. Peng, J. et al. Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopenia. Endocrinol. 149 1329-1337 (2007).
17. Claeysen, S., Joubert, L., Sebben, M., Bockaert, J. & Dumuis, A. A single mutation in the 5-HT4 receptor (5-HT4-R D100(3.32)A) generates a Gs-coupled receptor activated exclusively by synthetic ligands (RASSL). J. Biol. Chem. 278, 699-702 (2003).
18. Bruysters, M., Jongejan, A., Akdemir, A., Bakker, R.A. & Leurs, R.A.G. (q/11)-coupled mutant histamine H(1) receptor F435A activated solely by synthetic ligands (RASSL). J. Biol. Chem. 280, 34741-34746 (2005).
19. Kristiansen, K. et al. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT(2A) serotonin receptor but does not participate in activation via a "satt-bridge disruption" mechanism. J. Pharmacol. Exp. Ther. 293, 735-746 (2000).
20. Srinivasan, S., Santiago, P., Lubrano, C., Vaisse, C. & Conklin, B.R. Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo. PLoS ONE 2, e668 (2007).
21. Chang, W.C. et al. Modifying ligand-induced and constitutive signaling of the human 5-HT4 receptor. PLoS ONE 2, e1317 (2007).
22. Hsiao, E.C. et al. Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass. Proc. Natl. Acad. Sci. USA 105, 1209-1214 (2008).
23. Pauwels, P.J. Unravelling multiple ligand-activation binding sites using RASSL receptors. Trends Pharmacol. Sci. 24, 504-507 (2003).
24. Bender, D., Holschbach, M. & Stocklin, G. Synthesis of n.c.a. carbon-11 labelled clozapine and its major metabolite clozapine-N-oxide and comparison of their biodistribution in mice. Nucl. Med. Biol. 21, 921-925 (1994).
25. Pausch, M.H. G-protein-coupled receptors in Saccharomyces cerevisiae high-throughput screening assays for drug discovery. Trends Biotechnol. 15, 487-494 (1997).
26. Dohlman, H.G., Thorner, J., Caron, M.G. & Lefkowitz, R.J. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60, 653-688 (1991).
27. Li, B. et al. Rapid identification of functionally critical amino acids in a G protein-coupled receptor. Nat. Methods 4, 169-174 (2007).
28. Minic, J., Sautel, M., Salesse, R. & Pajot-Augy, E. Yeast system as a screening tool for pharmacological assessment of g protein coupled receptors. Curr. Med. Chem. 12, 961-969 (2005).
29. Shapiro, D.A., Kristiansen, K., Weiner, O.M., Kroeze, W.K. & Roth, B.L. Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J. Biol. Chem. 277, 11441-11449 (2002).
30. Violin, J.D. & Lefkowitz, R.J. Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol. Sci. 28, 416-422 (2007).
31. Cherezov, V. et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258-1265 (2007).
32. Roth, B.L. Drugs and valvular heart disease. N. Engl. J. Med. 356, 6-9 (2007).
33. Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G-protein-coupled receptors: Cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch. Pharmacol. 366 381-416 (2002).
34. Kenakin, T. Efficacy at G-protein-coupled receptors. Nat. Rev. Drug Discov. 1, 103-110 (2002).
35. Srinivasan, S. et al. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J. Clin. Invest. 114, 1158-1164 (2004).
36. Winzell, M.S. & Ahren, B. G-protein-coupled receptors and islet function-implications for treatment of type 2 diabetes. Pharmacol. Ther. 116, 437-448 (2007).
37. Scearce-Levie, K., Lieberman, M.D., Elliott, H.H. & Conklin, B.R. Engineered G protein coupled receptors reveal independent regulation of internalization, desensitization and acute signaling. BMC Biol. 3, 3 (2005).